Allison Naleway to Herpes Zoster Vaccine
This is a "connection" page, showing publications Allison Naleway has written about Herpes Zoster Vaccine.
Connection Strength
0.319
-
Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data. Am J Epidemiol. 2023 Feb 01; 192(2):205-216.
Score: 0.201
-
Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination. Mayo Clin Proc. 2015 Jul; 90(7):865-73.
Score: 0.118